INTRODUCTION: Neuropathological studies report varying patterns of brain mineralization in Parkinson's diseases (PD), progressive supranuclear palsy (PSP), and Parkinson variant of multiple system atrophy (MSA-P). Susceptibility-weighted imaging (SWI) is the ideal magnetic resonance imaging (MRI) technique to detect mineralization of the brain. The purpose of this study was to test if SWI can differentiate PD, PSP, and MSA-P. METHODS: Eleven patients with PD, 12 with PSP, 12 with MSA-P, and 11 healthy controls underwent SWI of the brain. Hypointensity of putamen, red nucleus, substantia nigra, and dentate nucleus in all groups were measured using an objective grading scale and scored from 0 to 3. RESULTS: In PSP, hypointensity score of red nucleus was higher than that in MSA-P (p=0.001) and PD (p=0.001), and a score of ≥ 2 differentiated the PSP group from the PD and MSA-P groups. Putaminal hypointensity score was higher in PSP when compared to that in PD (p=0.003), and a score of ≥ 2 differentiated PSP from PD groups. SWI hypointensity scores of red nucleus and putamen had an excellent intrarater and interrater correlation. Substantia nigra hypointensity score of the PSP group was higher than that of the MSA-P (p=0.004) and PD (p=0.006) groups, but the scores had only a moderate intrarater and interrater correlation. CONCLUSIONS: SWI shows different patterns of brain mineralization in clinically diagnosed groups of PD, PSP, and MSA-P and may be considered as an additional MR protocol to help differentiate these conditions.
INTRODUCTION: Neuropathological studies report varying patterns of brain mineralization in Parkinson's diseases (PD), progressive supranuclear palsy (PSP), and Parkinson variant of multiple system atrophy (MSA-P). Susceptibility-weighted imaging (SWI) is the ideal magnetic resonance imaging (MRI) technique to detect mineralization of the brain. The purpose of this study was to test if SWI can differentiate PD, PSP, and MSA-P. METHODS: Eleven patients with PD, 12 with PSP, 12 with MSA-P, and 11 healthy controls underwent SWI of the brain. Hypointensity of putamen, red nucleus, substantia nigra, and dentate nucleus in all groups were measured using an objective grading scale and scored from 0 to 3. RESULTS: In PSP, hypointensity score of red nucleus was higher than that in MSA-P (p=0.001) and PD (p=0.001), and a score of ≥ 2 differentiated the PSP group from the PD and MSA-P groups. Putaminal hypointensity score was higher in PSP when compared to that in PD (p=0.003), and a score of ≥ 2 differentiated PSP from PD groups. SWI hypointensity scores of red nucleus and putamen had an excellent intrarater and interrater correlation. Substantia nigra hypointensity score of the PSP group was higher than that of the MSA-P (p=0.004) and PD (p=0.006) groups, but the scores had only a moderate intrarater and interrater correlation. CONCLUSIONS: SWI shows different patterns of brain mineralization in clinically diagnosed groups of PD, PSP, and MSA-P and may be considered as an additional MR protocol to help differentiate these conditions.
Authors: E Mark Haacke; Norman Y C Cheng; Michael J House; Qiang Liu; Jaladhar Neelavalli; Robert J Ogg; Asadullah Khan; Muhammad Ayaz; Wolff Kirsch; Andre Obenaus Journal: Magn Reson Imaging Date: 2005-01 Impact factor: 2.546
Authors: Vivek Sehgal; Zachary Delproposto; E Mark Haacke; Karen A Tong; Nathaniel Wycliffe; Daniel K Kido; Yingbiao Xu; Jaladhar Neelavalli; Djamel Haddar; Jürgen R Reichenbach Journal: J Magn Reson Imaging Date: 2005-10 Impact factor: 4.813
Authors: Thomas Eckert; Michael Sailer; Joern Kaufmann; Christoph Schrader; Thomas Peschel; Nils Bodammer; Hans Jochen Heinze; Mircea Ariel Schoenfeld Journal: Neuroimage Date: 2004-01 Impact factor: 6.556
Authors: Y Wang; S R Butros; X Shuai; Y Dai; C Chen; M Liu; E M Haacke; J Hu; H Xu Journal: AJNR Am J Neuroradiol Date: 2011-11-03 Impact factor: 3.825
Authors: F J A Meijer; A van Rumund; B A C M Fasen; I Titulaer; M Aerts; R Esselink; B R Bloem; M M Verbeek; B Goraj Journal: AJNR Am J Neuroradiol Date: 2014-10-22 Impact factor: 3.825
Authors: I Hwang; C-H Sohn; K M Kang; B S Jeon; H-J Kim; S H Choi; T J Yun; J-H Kim Journal: AJNR Am J Neuroradiol Date: 2015-09-03 Impact factor: 3.825